Cargando…
Evaluation of Current Therapies for COVID-19 Treatment
The virus SARS-CoV-2, the etiological agent of COVID-19, is responsible for more than 400,000 deaths worldwide as of 10 June 2020. As a result of its recent appearance (December 2019), an efficacious treatment is not yet available. Although considered a lung infection since its emergence, COVID-19 i...
Autores principales: | Sethi, Atin, Bach, Horacio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463960/ https://www.ncbi.nlm.nih.gov/pubmed/32707942 http://dx.doi.org/10.3390/microorganisms8081097 |
Ejemplares similares
-
Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks
por: Wooding, Denise J., et al.
Publicado: (2020) -
Current and Future Development in Lung Cancer Diagnosis
por: Nooreldeen, Reem, et al.
Publicado: (2021) -
‘Treatment of COVID-19 with convalescent plasma’ – Author’s reply
por: Wooding, Denise J., et al.
Publicado: (2021) -
Development of Coronavirus Treatments Using Neutralizing Antibodies
por: Fouladirad, Saman, et al.
Publicado: (2021) -
Evaluation of current diagnostic methods for COVID-19
por: Alpdagtas, Saadet, et al.
Publicado: (2020)